AndroGel Lawsuit Update: Dates Set for 2016 & 2017 Trials

AndroGel lawsuit update
“Low-T,” a condition created largely using aggressive pharmaceutical marketing efforts, is treated using supplemental testosterone therapy products. Of products used to treat “Low T,” AndroGel is the most commonly prescribed. However, due to questionable marketing tactics and an increased risk of potentially deadly side effects, several lawsuits have been filed against AndroGel’s manufacturer, AbbVie, Inc.

The most recent AndroGel lawsuit updates have changed how these lawsuits will be addressed across the country. A multidistrict litigation (MDL) has been created to consolidate 32 testosterone cases in the initial pool of lawsuit claims. The MDL is expected to go before a judge and jury in 2016 and 2017. There are currently over 3,000 lawsuits in progress, which have been collectively filed against every major producer of testosterone therapy products.

What Does The MDL Mean for Consumers?

As the lawsuits against testosterone manufacturers began piling up, the U.S. District Court of Illinois approved creation of the MDL for similar cases to prevent conflicting rulings and unnecessary duplicate discoveries.

Judge Matthew F. Kennelly ruled, after reviewing the initial 16 cases against testosterone manufacturers, that lawsuits against AbbVie will be processed first, as they are the most common. The reasoning behind this decision is that understanding how these cases play out will provide deeper understanding into how future litigation may proceed.

For consumers filing lawsuits against AbbVie, the MDL means increased efficiency in processing and handling cases. The MDL was specifically designed to streamline the legal processes consumers are facing, so their attorneys can share resources and consolidate their legal arguments. Anyone with a present lawsuit, or anyone who may need to file an AndroGel claim in the future, will join this MDL whether they file before or after a judgement or settlement is reached.

Common Symptoms and Side Effects of AndroGel

Testosterone replacement therapy have been widely promoted for treating issues related to “Low T” such as erectile dysfunction, low sex drive, low muscle mass, and fatigue. However, despite claims to solve these issues, reports show that the clinical benefits do not outweigh the risks for healthy men to take testosterone. Often, for those who experience side effects, testosterone therapy does not actually address the issues it is purported to treat.

In reality, “Low-T” is a condition invented through marketing techniques to sell more products. Those who medically need testosterone therapy are those who do not produce testosterone naturally due to related medical issues or genetic conditions.

Heart attacks, strokes, and blood clots are AndroGel’s primary side effects that have resulted in the majority of current lawsuits. However, other reported complications include hormonal imbalances, prostate cancer, sleep apnea, and other cardiovascular events.

AndroGel Lawsuit Update: How Will the Trials Play Out?

In 2016, the initial 32 cases (16 chosen by the plaintiffs and defendants, respectively) that allege that AndroGel led to blood clot and heart-related injuries will be addressed judicially first. Depending on the evidence presented and the cases built on either side, there is potential for settlements between plaintiffs and AbbVie that could apply to all cases.

At present, the schedule for these AndroGel cases is as follows:

  • March 1, 2016: The 32 cases will be whittled down to three blood-clotting cases and three heart attack cases.
  • October 31, 2016: The first of the blood clotting cases will begin trial. The other two will begin on December 5, 2016, and January 9, 2017, respectively.
  • February 13, 2017: The first case related to heart attacks caused by AndroGel will begin. The other two trials will begin on March 20, 2017, and April 24, 2017, respectively.

The hope for these early cases is to set precedence for the remaining claims in the MDL not selected to serve as bellwether cases.

Have you or someone you loved been prescribed AndroGel for “Low-T”? Has this resulted in unexpected health complications? Submit your AndroGel lawsuit claim for a free case review and we can help determine if you should take legal action to join the AndroGel MDL.


  • Stay up-to-date with the latest news, upcoming cases, attorney profiles and new changes in the law direct to your inbox.